The existing legal frameworks in the United States (US) and the European Commission (EC) that regulate industrial chemicals represent divergent methods for controlling market entry, market restriction, and subsequent regulatory oversight when enforcement of these mechanisms fail. Contrary to the prevailing view that the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) law, which amended the US Toxic Substances Control Act (TSCA), is the 'gold standard' for chemical regulation, the central premise of this article is that the Frank R. Lautenberg Chemical Safety Act for the 21st Century provides unique opportunities for preventing environmental releases from new and existing chemical substances, which amounts to, if not more stringent, than REACH.
INTRODUCTION
The manufacturing, processing, use, and disposal of products that contain specific chemical properties are ongoing activities that ultimately lead to the presence of detectable levels of chemicals in the environment.
1
Though the mere detection of a chemical does not amount to risk per se, its presence in environmental media and humans may indicate that specific regulatory provisions that are designed to minimize exposures to it have failed. 2 Chemical manufacturers are required to comply with strict regulations that require limits or outright bans on the levels of chemicals that may enter the environment. For example, under the United States' Toxic Substances Control Act (hereinafter TSCA), the U.S. Environmental Protection Agency (hereinafter 'EPA' or the ' Agency') evaluates pre-manufacturing notifications (PMNs) for new chemical substances. PMN submissions require all available information on chemical identity, production volume, by-products, use, environmental release, disposal practices, human exposure, and existing available test information.
After its review, EPA may approve a PMN with specific limitations or bans (e.g., no releases to water). These types of restrictions are based on EPA's conclusion that '… the substance may present an unreasonable risk of injury to human health or the environment'. 3 Similarly, under the European Commission's (EC) Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) law, the European Chemicals Agency (ECHA) is tasked with ensuring compliance with strict specifications on whether acceptable environmental releases of chemicals may occur. As with TSCA, REACH or the environment, although they do support that environmental releases and exposures are in fact occurring. 10 TSCA and REACH represent divergent methods for controlling market entry, market restriction, and subsequent regulatory oversight when these mechanisms fail. Under TSCA, the EPA plays a role akin to having the 'guards watch the inmates', whereas under REACH, ECHA plays a role akin to having 'inmates guard the prison' with periodic check-ins by the guards. Though contrary to the prevailing view that REACH is the 'gold standard' for chemical regulation, the central premise of this article is that the Frank R. Lautenberg Chemical Safety Act for the 21st Century, which made important changes to TSCA, provides unique opportunities for preventing environmental releases from new and existing chemical substances, which amounts to, if not more stringent, than REACH.
This article continues in section 2 with an overview of the market entry provisions for new chemical substances under Lautenberg and REACH. Thereafter, section 3 focuses on the specific triggers that typically drive regulatory intervention, more stringent risk management measures, or even bans on existing chemical substances under these laws. The administrative and legal provisions that accompany market restrictions are also discussed. Section 4 moves forward with an evaluation of subsequent remedial measures in the U.S. and the E.C. that accompany media-specific regulation of existing chemicals. Finally, section 5 provides conclusions and recommendations on maximizing the utility of Lautenberg and international cooperation on Lautenberg and REACH.
MARKET ENTRY OF NEW CHEMICAL SUBSTANCES IN THE US AND EC
Regulatory agencies administer the laws that provide specific frameworks for evaluating new and existing substances. These are 10 Fourth National Report on Human Exposure to Environmental Chemicals (Centers for Disease Control and Prevention 13 June 2014). www.cdc.gov/ exposurereport/pdf/fourthreport.pdf. Accessed on 18 September 2016. The measurement of an environmental chemical in a person's blood or urine does not by itself mean that the chemical causes disease. Advances in analytical methods allow us to measure low levels of environmental chemicals in people, but separate studies of varying exposure levels and health effects are needed to determine whether such blood or urine levels result in disease.
typically country-or region-specific, and have different data requirements depending on the regulatory status of the substance (e.g., new or existing substance). For example, in the U.S., manufacturers only need to submit health and safety information in their possession at the time of filing a PMN under TSCA, whereas in the EC, specific tests are mandated, regardless of the regulatory status, based on the intended production volume under REACH. In the discussion that follows, a general overview of Lautenberg and REACH is provided, along with the specific market-entry provisions of each.
TSCA: New Chemical Substances
After finding that human beings and the environment are exposed to large numbers of chemical substances and mixtures each year, 11 the United States Congress passed TSCA in 1976 (hereinafter the 'Old' TSCA) with the purpose of preventing unreasonable risks of injury to health or the environment through the manufacture, processing, distribution in commerce, use, or disposal of chemical substances.
12
At that time, there was 'widespread agreement' that the primary chemical management law of the United States was ineffective, outdated, and in need of reform. hazardous to human health and the environment.
16
In June of 2016, Congress modernized the chemicals management law with the passage of the Frank R. Lautenberg Chemical Safety Act for the 21st Century (hereinafter Lautenberg).
17
The passage of Lautenberg amended 'Old' TSCA and enhanced many of its deficient provisions by broadening the Agency's authority to, inter alia, better ensure the safety of all new and existing chemicals, require testing, reduce testing on vertebrates, and limit companies' ability to conceal information.
18
The amendment strengthened human health protections by explicitly requiring protection of vulnerable populations, such as children, pregnant women, workers and the elderly.
19
Lautenberg authorizes EPA to oversee the manufacture, use, and importation of chemical substances in the U.S. by requiring reporting, record keeping, and testing requirements, in addition to setting restrictions for 'production, importation, use and disposal' of chemical substances.
20
Under the TSCA, a chemical substance is defined as any organic or inorganic substance of particular molecular identity not including mixtures, pesticides, tobacco, source materials, articles, or food additives. 21 Furthermore, the term manufacture is defined to include not only manufacture and production, but also any import into the customs of the US.
22
The manufacturing and processing notice requirements are laid out under Section 5 of TSCA. Manufacturers, importers, and processors are required to submit PMNs to the EPA administrator prior to manufacturing new chemical substances or significant new use notifications (SNUNs) for substances with significant new uses. 23 [T]he projected volume of manufacturing and processing of a chemical substance, the extent to which a use changes the type or form of exposure to human beings or the environment to a chemical substance, the extent to which a use increases the magnitude and duration of exposure of human beings or the environment to a chemical substance, and the reasonably anticipated manner and methods of manufacturing, processing, distribution in commerce, and disposal of a chemical substance.
24
Under the 'Old' TSCA, after a PMN or SNUN was submitted, the PMN or SNUN was considered approved within 90 days unless EPA concluded that the PMN lacked sufficient data to determine the effects on health and the environment or whether it presented an unreasonable risk to human health or the environment. 25 If both determinations were met, EPA could issue a proposed order to place specific restrictions on the chemical substance.
Lautenberg retained much of Section 5 of the TSCA, but made significant alterations that increased the Agency's obligation, while providing the Agency more flexibility in evaluating the safety of new chemicals.
26
Before a new chemical can enter into commerce, Lautenberg explicitly requires the Agency to make one of three affirmative determinations concerning whether a new chemical or SNU presents or may present an 'unreasonable risks to a potentially exposed or susceptible subpopulation …' and take the required actions. 27 First, that the new chemical or SNU presents an unreasonable risk of injury to health or the environment, the Agency is required to regulate under Section 5(f).
28
EPA must also promulgate a Significant New Use Rule (SNUR) or explain why it is not taking this step.
29
A n SNUR can be placed on a chemical after EPA reviews an initial PMN and places restrictions on that PMN in the form of a consent order with the submitting manufacturer. Chemical SNURs: §5(e) SNURs and non- §5(e) SNURs. 31 The §5(e) SNUR essentially mimics the terms and conditions of the consent order. Non- §5(e) SNURs are used when EPA has not found an unreasonable risk from the manufacture, processing, use, and disposal during the PMN review, but determines that potential new uses may increase the likelihood of an unreasonable risk through higher exposure(s).
32
Under the second alternative, (1) if the information available is insufficient to permit a reasoned evaluation of the effects of the chemical; (2) or in the absence of sufficient information, the substance may present an unreasonable risk to health or the environment; (3) or such substance will be produced in substantial quantities and it either enters or may be anticipated to enter the environment in substantial quantities or there is or may be significant or substantial human exposure. 33 If any of the determinations are met, the Agency is required to issue an order under Section 5(e) and to either implement a SNUR regulating use of the substance or explain why it is not taking this step.
34
Lautenberg significantly broadened the scope of the Agency's regulatory authority by changing the first italicized 'or' from 'and'. 35 This subtle revision allows EPA to regulate a chemical based solely on a lack of information.
The Administrator must require that testing be conducted if it determines that the chemical substances may present an unreasonable risk to the health or the environment, or lacks sufficient information. 36 Section 4 of Lautenberg provides EPA more flexible authority to require testing by use of rule, orders, or consent agreement.
37
Section 4(a)(4) specifies the use of a tiered screening and testing process unless available information supports moving on to more advanced testing. persistent, bio accumulative, and toxic).
39
The 'Old' TSCA limited this provision to only chemical mixtures known to cause cancer, genetic mutations, or birth defects. 40 Lautenberg also added a new section to TSCA that requires the Agency to reduce and replace vertebrate animal testing to the extent practical when this can be scientifically justified 41 and to develop and implement a plan to promote the use of alternative non-vertebrate animal-based testing methods. 42 Third, that the new chemical or SNU is not likely to present an unreasonable risk, in which case, the submitter can commence manufacture or processing for SNU. 43 If this determination is made, EPA is required to publish a statement of its finding. 44 It is noteworthy to mention that in drafting Lautenberg, legislation neglected to define the key term 'unreasonable risks.' 45 This slight omission may be regarded as problematical for the Agency in future litigation in determining which risk are deemed reasonable or unreasonable.
The import and export of chemical substances to and from the US are also covered under the United State's Chemical Regulatory Act. Imports are considered a form of manufacturing as defined by Section 2 of TSCA; therefore, an imported chemical substance that fails to comply with the regulations shall be refused entry into U.S. customs territory.
46
Companies importing chemical substances into the U.S. must notify the EPA if it is considered a significant new use in order to comply with TSCA Section 5(a).
47
For exporting chemical substances, companies must only comply with Section 12 with regard to reporting/retaining information, unless it is proven that such substance is being manufactured, processed, or distributed for commerce in the US. 48 In conclusion, EPA reviews new substance notifications (e.g., PMNs or SNUNs) and places specific testing or risk management provisions on market entry. The manufacture of a new chemical can only begin once EPA confirms it is likely to meet the safety 'protocols and 39 ibid s 5(a). 40 ibid. Under Lautenberg, EPA is empowered with broad authority to regulate new substances (e.g., production volume-based triggers or a ban pending upfront testing) or potentially to prohibit the manufacture of new substances altogether. At first blush, many of the provisions under Lautenberg, especially with regard to assessing potential risks from new chemicals, appear to be preserved under REACH. The differences that preclude such a conclusion will be addressed next.
ibid s 4(h)(1)(A). 42 ibid s 4(h)(1)(A)(i). 43 ibid s 5(a

REACH: New Chemical Substances (non-phase-in substances)
In June 2007, the EC adopted REACH in order to improve the protection of human health and the environment from chemicals manufactured and imported into the European Union.
52
REACH requires manufacturers and importers of chemicals to identify and manage the risks associated with all stages of the chemical's lifecycle by establishing procedures for collecting and assessing information on the substances.
53
A company planning on manufacturing or importing a chemical in quantities greater than one ton per year must register the substance to ECHA. submit a substance for general registration purposes. 55 The registration of a chemical must include a technical dossier in addition to a chemical safety report (CSR) . 56 The identity of the manufacturer(s) or importer(s), the identity of the substance, guidance on safe use of the substance, study summaries on information derived from the application of Annexes VII to XI, an indication of review by an assessor chosen by the manufacturer or importer, and proposals for testing must be included in the technical dossier for proper registration.
57
REACH has specific data requirements, including performance of studies under GLP standards, for substances depending on the annual production/import volume. 58 The amounts relevant to varying levels of scrutiny include specific quantity triggers for new and existing substances produced/imported in quantities greater than 1, 10, 100, or 1,000 tons or more. 59 The requirements build on each other, thus requirements for substances in quantities of 1,000 tons or more include the testing requirements of the lower quantities and so on.
A CSR is required for all substances registered for manufacture/ import once the quantities are up to 10 tons or more per year.
60
The CSR documents the chemical safety assessment, which includes human health hazard assessment, physicochemical hazard assessment, environmental hazard assessment, PBT (i.e., persistent, bio accumulative, and toxic), and vPvB (i.e., very persistent and very bio accumulative) assessments. 61 If assessments on human health hazards or PBT/vPvB reveal that the substance meets the criteria to be classified as dangerous, then the safety assessment must include risk characterization and an exposure assessment with exposure scenarios and exposure estimation as well.
62
The risk characterization consists of a comparison of the exposure of each human population likely to be 55 ibid 24, art 10. 56 ibid 24-25, art 10(a) and (b). 57 ibid. 58 ibid 7, para 37; see also: ibid 26, art 13, para 4 ('Eco toxicological and toxicological tests and analyses shall be carried out in compliance with the principles of good laboratory practice provided for in Directive 2004/10/EC or other international standards recognized as being equivalent…). 59 ibid 103-106 (Annex VII). See also 107-110 (Annex VIII), 111-115 (Annex IX), and 116-118 (Annex X). 50 ibid 26, art 14, para 1. 61 ibid 27, art 14, para 3 (a)-(d). 62 ibid 27, art 14, para 4 (a)-(b).
exposed with derived no-effect levels (DNELs), a comparison of the predicted environmental concentration with predicted no-effect concentrations (PNECs), and an assessment of the likelihood and severity of an event occurring because of the physiochemical properties of the substance. 63 In conclusion, REACH provides a tiered-testing approach for evaluating new and existing substances through mandatory testing, evaluation of risk(s), and implementation of risk management measures. In addition, study summaries or robust study summaries are required with regulatory dossiers for new and existing chemicals; however, full study reports with 'raw data' are not required. Market entry is premised on the outcome of risk determinations, which are initially made by the manufacturer, not the regulator (i.e., ECHA). 64 The foregoing approach creates significant vulnerabilities with REACH because GLP standards, which include the requirements for documenting and archiving raw data, were initially developed to address research fraud that was occurring at contract laboratories. 65 Oftentimes, errors or even outright fraud will go undetected, unless the 'raw data' from a study are available for comparison with summary data from the same study. 66 As discussed in the next section, the irony of this approach is that manufacturers routinely request access to the underlying 'raw data' for studies that are used to drive market restrictions on their chemicals. In two studies, the raw data had significant errors. In one case (involving two different studies from the same investigator) multiple pups were misassigned to litters, and multiple litters were misassigned to dosed groups. Another investigator inadvertently omitted entire blocks of data dealing with eight highdose animals. These errors were detected (and corrected) only because the Statistics Subpanel had access to summary data in published papers for comparative purposes.').
MARKET RESTRICTION OF EXISTING CHEMICAL SUBSTANCES IN THE US AND THE EC
Market restrictions on chemicals often start with the publication of findings, typically highly controversial ones, which indicate widespread environmental contamination and/or previously unidentified adverse health effects (e.g., developmental neurotoxicity).
67
Brominated flameretardants are a contemporary example that satisfies each of these situations. The chemicals that make up this functional category of compounds is quite diverse, yet the category known as polybrominated diphenyl ethers (PBDEs) is by far the most known example.
Early reports of environmental contamination from decabromodiphenyl oxide (Deca), a PBDE, began in the 1980s. The above example with Deca illustrates how existing chemicals may end up with market restrictions in the absence of formal regulatory intervention. This type of voluntary action can facilitate subsequent regulatory activities that allow regulators to ensure market restrictions. As discussed below, in the absence of cooperative agreements between regulators and the regulated community, the regulatory hurdles for restricting and potentially banning existing chemical substances under Lautenberg are far less arduous than they were under the 'Old' TSCA and REACH.
TSCA: Existing Chemical Substances
Chemicals, like Deca, that were in the stream of commerce prior to the enactment of TSCA (of 1976) were 'grandfathered in' and immediately added to the TSCA inventory as 'existing chemical substances.' For new chemical substances, once EPA completes its PMN evaluation and the submitter completes a Notice of Commencement of Manufacture or Import, the new chemical substance is added to the TSCA inventory and is then considered an existing chemical substance.
73
Under the 'Old' TSCA, once a chemical was designated an existing chemical substance, EPA had no duty to evaluate the substance and its options for subsequent regulatory activity were limited and open to administrative and legal challenges. For example, under Section 4 of the 'Old' TSCA, EPA was required to make a statutory finding of 'data inadequacy' and 'testing is necessary' in order to require manufacturers, by test rule, to perform hazard or exposure testing. 74 Section 4 of the 'Old' TSCA test rules were, however, time consuming and often took years to finalize because of the Agency's requirement to follow lengthy rule-making procedures set forth under the Administrative Procedure Act (APA), as well as the challenges that the regulated community may lodge. the subsequent testing added additional months or years before EPA eventually obtained the required data. 76 Under Section 6 of the 'Old' TSCA, if EPA found a 'reasonable basis to conclude' that the manufacture or importation of a chemical substance 'presents or will present' an unreasonable risk of injury to health or the environment, 77 EPA could, in theory, take action to ban or limit the manufacture, processing or use of the chemical. As demonstrated in the following example, implementation of these actions under the pre-existing statutory language was problematic.
EPA previously attempted to issue a TSCA Section 6 rule that would have effectively banned asbestos, a known human carcinogen; 78 however, the rule was challenged in court and, on appeal, the court overturned EPA's proposed rule for failing to consider a number of factors, required under the 'Old' TSCA, including, for example, the benefits of asbestos, the alternatives, and least burdensome measures. The limitations on EPA's ability to regulate existing chemical substances have focused narrowly on Section 6 actions and formed the basis of TSCA reform initiatives. Section 4(a)(2) of Lautenberg grants EPA with a newfound authority to perform risk evaluations for existing chemicals under Section 6(b), 83 as well as use rules, orders, and consent agreements to obtain testing for review of PMNs and SNUNs under Section 5. 84 Lautenberg revisions removed the challenging language from Section 6 that required existing chemicals be regulated by the 'least burdensome requirement' 85 and mandates the evaluation of existing chemicals by establishing new risk-based safety protocols and methodologies to determine whether the chemical presents any 'unreasonable risks' to public health or the environment. 86 Section 6(a) of Lautenberg now requires that EPA classify chemicals as high or low priority substances to determine which chemicals it will prioritize for risk-based safety assessment.
87
The process requires EPA to perform a risk-based screening of chemicals relying on factors such as 'hazard and exposure potential, persistence and bioaccumulation, and storage near significant sources of drinking water.' 88 Low-priority designations do not require any further testing. 89 Observably, upon the discovery of new information, low-priority chemicals can be reclassified as high-priority. regulation to reduce the risk through use of labelling restrictions, bans, phase-outs, or restrictions on usage. 93 Lautenberg specifies aggressive timelines for each step of the assessment process. The entire risk evaluation process must be completed three and a half years after its commencement, with a possible six-month extension. 94 Under the 'Old' TSCA, costs could be considered when initially assessing risk; 95 however, under Section 6(b)(4) of Lautenberg, EPA may not factor in costs or other non-risk factors during the initial assessment.
96
If EPA decides to restrict a chemical, Lautenberg does require EPA to conduct a cost-benefit analysis to determine risk management options in which costs and the availability of alternatives must be taken into account.
97
EPA must promulgate risk management actions within two years after the completion of the risk evaluations, with a possible extension of up to an additional two years. 98 Many proponents of TSCA reform favoured the regulatory paradigm enforced in the EC under REACH. As indicated below, REACH offers a clear and transparent approach to regulating existing substances because it captures substances that were grandfathered under the EC's previous chemical control law. Recall that REACH does not require the submission of full study reports in support of regulatory dossiers. Rather, it requires the submission of robust data summaries, which lack the underlying 'raw data'. Furthermore, the lock step system of addressing regulatory disputes in the EC suffers from the same protracted timelines that accompany rule making initiatives under Section 4 of the 'Old' TSCA. 99
REACH: Existing Chemical Substances (phase-in substances)
In the European Union, new and existing chemical substances are evaluated identically. The only difference between the two is the established deadlines for submitting dossiers on specific existing for evaluating the registration dossier and issuing a recommendation to ECHA, which will, in turn, informs the EC, the registrant, and other Member States within 12 months after initiation of evaluation, or within 12 months after the receipt of further information requested in support of evaluation. 105, 106 Mechanisms for judicial review are available when disagreements arise on the relevance and choice of specific data to use for identifying risks and appropriate risk management measures. For example, once a registrant submits a dossier to ECHA, the relevant Member States (e.g., those where manufacturing takes place) are informed of ECHA's initial evaluation and are afforded the opportunity to comment.
ibid s 6(d)(1)(D). 94 ibid s 6(b)(2)(A). 95 ibid s (6)(a). 96 ibid s 6(b)(4)(A). 97 ibid s 6(b)(2)(C). 98 ibid s 8(b)(4)(E)(ii)(I
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If a registrant disagrees with ECHA's draft decision (e.g., identified as a substance of very high concern and recommendation [SVHC] for authorization), the registrant may challenge the decision in the form of an appeal to the Board of Appeal. 108 Once filed, the appeal has a suspensive effect on the disputed decision.
109
If the appeal is denied, the registrant may bring an action before the Court of First Instance or the Court of Justice of the European Union.
110
In conclusion, REACH offers a transparent and structured approach for evaluating regulatory dossiers and for handling regulatory disputes; however, time-consuming procedural steps, which apply to both existing and new chemical substances, accompany this structured system. Similarly, timely procedural obstacles hindered the evaluation and regulation of existing chemical substances under the 'Old' TSCA. Unlike REACH, new and existing chemical substance evaluations under Lautenberg are virtually unhindered by these types of delays.
ENFORCEMENT AND COMPLIANCE OF RESTRICTIONS PLACED ON EXISTING CHEMICAL SUBSTANCES IN THE US AND THE EC
Regardless of the types of restrictions placed on chemical substances, the subsequent regulatory approaches used for addressing environmental contamination in the US and the EC provide insight on the disconnect that exists between the pre-and post-market regulation of chemical substances under registration laws (e.g., TSCA and REACH) versus media-specific laws (e.g., Clean Water Act). In this context, contamination refers to the identification of a regulated chemical in a medium (e.g., water) where the chemical is banned or exceeds an allowable level. In both jurisdictions, retroactive approaches are used for addressing contamination, despite opportunities for proactive enforcement and compliance of restrictions established under the registration laws. As discussed in this section, Lautenberg and REACH provide several opportunities for regulators and citizens to interject and ensure compliance with pre-existing restrictions (e.g., Lautenberg Section 5(e) SNURs), which could serve to avoid the time and costs with establishing the downstream retroactive regulatory approaches that are typically pursued.
United States of America
Many chemicals identified as contaminants of emerging concern were exempted under the 'Old' TSCA in the sense that they were grandfathered in when TSCA was enacted.
111,112
For these classes of compounds (e.g., PBDEs and some perfluorinated compounds), TSCA Section 5(e) SNURs generally do not exist and their regulation would have proceeded only after they were detected in the environment through media-specific laws, but only after years of data collection and a lengthy rule-making process. Specific requirements exist that preclude a timely response to concerns over environmental contaminants. For example, under the Clean Water Act, the Agency must take into account specific factors to list additional toxic pollutants 113 and make a statutory finding that the contamination occurred due to a direct discharge from a point source into navigable waters where the polluter either: 1) did not obtain a National Pollutant Discharge Elimination System (NPDES) permit, or 2) exceeded the discharge limit for a permitted pollutant. 114 However, environmental releases may go undetected when no point source monitoring requirements exist or when releases occur in a diffuse manner that does not require NPDES permits, as discussed next in a real world example.
In 1989, a manufacturer of Deca submitted a PMN to EPA for decabromodiphenyl ethane, a compound that is not a PBDE, but is structurally similar to Deca.
115
EPA entered into a consent order with the submitter and approved the PMN. Subsequently, in 1993, EPA issued a TSCA §5(e)-SNUR that called for 'no release to US waters', which applied to the manufacturer and its customers. with enforcement initiatives to improve compliance. Arguably, this approach is retroactive, although it represents a more expeditious approach than addressing environmental releases through media-specific regulations.
A second option, related to option 1, includes citizen actions under the False Claims Act (FCA).
121
Under the FCA, a party who knowingly submits false claims to the government is liable for treble the damages in addition to a fine that ranges from US$5,000 to US$11,000 per violation. 
125
A final option is to include monitoring requirements under consent orders or §5(e)-SNURs. Under this option, monthly monitoring could be tied to the general NPDES permits, whereby the registrant analyses for the TSCA-regulated chemical, along with the chemicals included on the NPDES permit, to ensure compliance.
As indicated in the foregoing discussion, Lautenberg establishes clear restrictions on chemical substances that, if complied with, can ensure environmental protection. Observably, regardless of the restrictions placed on chemical substances, compliance monitoring and enforcement activities are critical for ensuring that non-compliant facilities are brought into compliance. In the absence of these activities, environmental contamination may go on for years or even decades, before media-specific approaches for addressing the contamination are initiated at the state or regional level.
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However, as discussed below, the interplay between REACH and the EC's media-specific laws (e.g., the Water Framework Directive) are seemingly slanted towards future retroactive regulatory initiatives to address environmental contamination.
European Commission
The European Union employs a fundamentally different framework and procedure, than the US, for ensuring compliance and enforcement with pre-established environmental release values. REACH requires registrants to derive PNECs for evaluating potential risks to environmental compartments (e.g., surface water and sediment); The WFD was based on geographical and hydrological boundaries that led to the formation of river basins, rather than national/political boundaries. This directive represents a holistic framework for bringing waters in the European Union into 'good water status '. 128 Under Article 16 of the WFD, the EC is required to identify priority substances (i.e., those presenting a significant risk) based on, for example, Council Regulation (EEC) No 793/93 (repealed and replaced by REACH). 129, 130, 131 In 2001, the EC identified its first list of 33 priority substances 132 and, in 2008, amended the WFD, and developed environmental quality standards (EQSs). 133 PBDEs were identified among the list of priority substances and had the lowest EQSs derived from the list. 134 The WFD requires the EC to review the priority substance list every four years and consider other substances for possible inclusion. Through consultations, the EC concluded that EQSs were identified and set based on criteria, which were consistent with the criteria for SVHCs under REACH, and proposed amendment of the WFD once again. 136, 137 It follows from the above that the WFD and accompanying amendments represent a holistic approach for improving water quality in the European Union. Notably, with the passage of REACH and the ensuing proposal to use SVHC designation as a basis for identifying priority substances under the WFD, there are two immediate concerns that ensue. First, ECHA must select a chemical substance for evaluation. Then, after consultation through a community rolling action plan, it must be identified as an SVHC with a recommendation for authorization. At this stage, the registrant may lodge an article 92 challenge. Depending on the outcome, it may take several years before the chemical substance is selected for listing as a priority substance under the amended WFD. Second, penalties for non-compliance under the WFD are qualitatively described as those that are 'effective, proportionate, and dissuasive…' 138 The same qualitative language is used in REACH for non-compliance. Thereafter, EPA issued SNURs on these chemicals, which ensured that these compounds would not be manufactured or imported into the US without undergoing an evaluation by EPA.
Beyond the notification/registration laws, the US and the EC have post hoc media-specific laws, which propagate failed enforcement (e.g., TSCA) or oversight (e.g., REACH) that occurs during the notification/ registration process. Ironically, these failures continue despite the greater stringency required to list and regulate a chemical under mediaspecific laws. The CWA and the WFD have burdens of proof, including extensive data requirements and timely processes, before meaningful steps can be taken to address environmental contamination.
The foregoing examples support the need for changing the chemicals regulation debate to a non-partisan focus with the recognition that chemical exposures are not Democratic or Republican in nature, but rather issues that affect populations. The EC's WFD considers this and represents a significant step forward with addressing chemicals management. However a significant caveat applies following no requirement to provide full study reports, including 'raw data', as supporting information. This lack of data standard will likely weaken the value and utility for identifying SVHCs under REACH, as well as priority substances under the WFD.
The concern here is that this approach appears to favour the regulatory 'gamesmanship' that can drive business-based decisions. For example, if a registrant submits robust summaries under REACH that down play or mask the potential hazards of a compound, and then uses these data to calculate PNECs, the chances of detection are rather small. Of course, this assumes that a registrant's dossier is part of the five per cent of dossiers evaluated by ECHA, that ECHA will request the full study reports as a part of its evaluation, and that ECHA will review them and identify any false reporting.
Though provided as hypothetical, the above scenario is significant because chemical regulations have global impacts, and a failure under REACH may absolve successes under Lautenberg and vice versa. Therefore, greater interaction between regulatory agencies needs to take place when evaluating the potential risks of chemical substances. There have been some efforts in this direction. For example, on 17 December 2010, ECHA and EPA signed a statement of intent (SOI) for sharing data across jurisdictions, while at the same time, preserving confidential business information (CBI). 144 Notably, there was no indication that EPA approached or collaborated with ECHA on its recent existing chemical substance evaluations. 145 Given the prominence of EPA's assessments, it is doubtful that there is any cross-talk between these agencies on lower priority or lower visibility projects, let alone those that contain CBI (i.e., PMNs or non-phase in substances). Furthermore, there is no indication that any effort has been made to compare the robust summaries submitted under REACH with EPA's published substantial risk notifications under Section 8(e) of TSCA. It appears as though this would be a good starting point for identifying clandestine groups that may have tweaked robust summaries to avoid more stringent risk management measures in the European Union.
In conclusion, Lautenberg made important changes to TSCA, which appear to provide greater pre-and post-market scrutiny and restriction than REACH. The specific provisions under Lautenberg Section 5(e) SNURs capture media-specific releases, without the restrictions that accompany media-specific regulations (e.g., Clean Water Act and point source releases). Observably, once chemicals enter the environment, they are no longer a local problem and oftentimes become regional or even global problems. Therefore, it is critical that regulatory agencies around the world consider an international collaborative approach when drafting and harmonizing chemical control laws. This will ensure that chemical substances regulations are coordinated, consistent, and strategic which, in turn, will help assure the efficacy of laws among nations. Combining efforts internationally will make certain the strengths and weaknesses, like those identified herein under TSCA/ Lautenberg and REACH, and they will be addressed through drafting local regulatory frameworks with the understanding and intent that they will influence global issues.
